Trial intelligence / Profile preview

Therapy of polycythemia vera with pegylated interferon

DRKS00004658Phase 2Completed

Sponsor
Universitätsmedizin Mannheim
Start
Jan 2013
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

A Phase 2 trial of peginterferon alfa-2b in polycythemia vera (PV), sponsored by Universitätsmedizin Mannheim. Started Jan 2013; status: completed.

02

Drugs

peginterferon alfa-2b
03

Conditions

polycythemia vera (PV)

Beyond the preview

Go deeper on DRKS00004658.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00004658.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call